Labcorp Proposes Millennium Health Buyout for Drug Testing

Labcorp has proposed acquiring Millennium Health, a specialty laboratory, to add drug testing services, according to MedTech Dive. The reported transaction places a drug testing services expansion at the center of Labcorp’s proposed buyout of Millennium Health.

MedTech Dive described the Millennium Health proposal as Labcorp’s third buyout announcement in eight days. The publisher characterized Millennium Health as a specialty laboratory and reported that Labcorp is seeking to add drug testing services through the proposed acquisition.

Proposed acquisition focuses on drug testing services

The announced proposal involves Labcorp and Millennium Health, with drug testing services identified by MedTech Dive as the service area Labcorp aims to add. The report frames the transaction as a buyout of a specialty laboratory rather than as a separate laboratory service announcement.

For medical and laboratory sales professionals, the development is a portfolio event involving a laboratory organization and a specialty laboratory. The stated focus on drug testing services gives the announcement a defined service-area context for discussions about laboratory portfolios and specialty testing.

Third buyout announced in eight days

MedTech Dive reported that the proposed Millennium Health acquisition is the third Labcorp buyout announced in eight days. That sequence is part of the reported context surrounding the Millennium Health proposal.

The supplied MedTech Dive summary identifies the proposed acquisition, Millennium Health’s specialty laboratory position, Labcorp’s intended addition of drug testing services, and the timing of the third buyout announcement. The proposed buyout remains the central event reported by the publisher.

What the report establishes

MedTech Dive’s report establishes that Labcorp has proposed a Millennium Health buyout and that the stated purpose is to add drug testing services. It also establishes that Millennium Health is a specialty laboratory and that Labcorp announced three buyouts in eight days.

Medical and veterinary sales professionals following diagnostics and laboratory activity can use the announced proposal as a current example of a laboratory portfolio transaction focused on specialty testing services.